REG - Eden Research plc - Director/PDMR Shareholdings
Eden Research plc announced that its CEO, Sean Smith, purchased 390,624 ordinary shares at 2.56 pence each on 17 September 2025. Following this transaction, Smith holds a total of 3,059,768 shares, representing 0.57% of the company's issued share capital. Eden Research focuses on sustainable biopesticide and biocontrol technology, with products aimed at improving crop yields and marketability. The company is listed on AIM under the symbol EDEN and has been recognized for its contributions to the green economy.
London Stock Exchange·
